Bio-Rad Laboratories Inc. Class B
News
HIV/AIDS Diagnostics Market to Reach USD 9.6 Bn by 2031 | TMR Study
Accesswire WILMINGTON, DE / ACCESSWIRE / March 30, 2023 / Transparency Market Research Inc. - The global HIV/AIDS diagnostics market is projected to expand at a CAGR of 9.3% from 2022 to 2031 and exceed value of USD 9.6 Bn by 2031. Continuous technological innovations in POC technologies for HIV/AIDS has broadened the HIV/AIDS diagnostics market outlook. Increase in availability of POC testing is likely to accelerate the market and contribute to reduced AIDS-related morbidity and mortality. Download a Sample for Highlights on Market Drivers and Challenges Affecting the HIV/AIDS Diagnostics: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26582 Advancements in HIV rapid test kits are likely to propel the global HIV/AIDS diagnostics industry. Surge in awareness about advantages of rapid point-of-care HIV testing in women and vulnerable populations is likely to bolster the HIV/AIDS diagnostics market growth in the near future. Governments in several countries have framed policies that promote adoption of HIV testing among at-risk populations. more…
The 3 Most Promising Biotech Stocks to Buy Now
InvestorPlace This year the National Institutes of Health is set to request its biggest budget yet for 2024, on the heels of its previous biggest budget in 2023. As the COVID-19 pandemic fades from view, labs will switch back to other avenues of research, often funded by the NIH. This higher level of funding, coming on the heels of the COVID-19 pandemic and associated biotech boom, could be big money for the people who make and sell equipment. As the saying goes, in a gold rush, the best job is a shovel salesman. University labs are the biggest beneficiaries of NIH funding. These groups tend to be smaller than corporate labs and have less time to compare every product line when purchasing. Therefore, they tend to purchase from large, trusted companies above all else. I will be discussing three companies that are well-known by researchers, making them some of the most likely beneficiaries of the NIH’s largesse. Ultimately, these three companies have positioned themselves well as some of the most promising biotech stocks to buy in 2023. more…
Proteomics Global Market Report 2023
GlobeNewswire Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc. Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc. more…
Rapid Test Market to Exceed US$ 62.34 Bn by 2031: TMR Study
Accesswire WILMINGTON, DE / ACCESSWIRE / February 22, 2023 / Transparency Market Research Inc. - The rise in demand for laboratory rapid tests at hospitals are generating sizable lucrative opportunities for players in Rapid Test Market , mainly owing to their affordability. Hospitals thus present the fastest growing market for rapid tests, propelled by enormous application of the tests for a wide range of diseases. Of the various technologies, the study found that immunoassays accounted for the largest revenue generator in the rapid test market in 2021. The global market is forecast to expand at a CAGR of 8.0% during 2022-2031. The demand for products in the rapid test market is spurred by an explosive rise in demand for COVID-19 testing, including at-home tests. Of note, players are leaning toward integrating cutting-edge technologies for enabling accurate and rapid tests for COVID-19. A case in point is the growing popularity of the rapid antigen test (RAT), found in recent developments in the rapid test market Industry players in the rapid test market are keen on expanding the reach of services through hospital networks in various geographies. more…
Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Call Transcript
Seeking Alpha Bio-Rad Laboratories, Inc. (NYSE:NYSE:BIO) Q4 2022 Earnings Conference Call February 16, 2023 5:00 PM ETCompany ParticipantsEdward Chung - Vice President, Investor RelationsIlan Daskal -… more…